Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactiva...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Groothuis, J R, Simoes, E A, Lehr, M V, Kramer, A A, Hemming, V G, Rodriguez, W J, Arrobio, J, Welliver, R C, Siber, G R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.668
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!